| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Abatacept therapy and safety management
|
Pham, Thao
|
|
2009
|
|
S1 |
p. S3-S55
53 p.
|
article
|
| 2 |
Abatacept therapy and safety management
|
Pham, Thao
|
|
2012
|
|
S1 |
p. 3-84
82 p.
|
article
|
| 3 |
Biologic targeted therapies in pediatric rheumatology
|
Guillaume-Czitrom, Séverine
|
|
2014
|
|
S1 |
p. 2-3
2 p.
|
article
|
| 4 |
Canakinumab for the Patient With Difficult-to-Treat Gouty Arthritis: Review of the Clinical Evidence
|
Bardin, Thomas
|
|
2015
|
|
S1 |
p. eS9-eS16
nvt p.
|
article
|
| 5 |
3 Clinical situation: Management in the case of burns and trauma?
|
|
|
2005
|
|
S1 |
p. S58-
1 p.
|
article
|
| 6 |
3 Clinical situation: Management in the case of pregnancy?
|
|
|
2005
|
|
S1 |
p. S51-S54
4 p.
|
article
|
| 7 |
3 Clinical situation: Management in the case of surgery and dental care?
|
|
|
2005
|
|
S1 |
p. S49-S50
2 p.
|
article
|
| 8 |
3 Clinical situation: Management in the case of travel?
|
|
|
2005
|
|
S1 |
p. S57-
1 p.
|
article
|
| 9 |
3 Clinical situation: Management in the case of vaccinations?
|
|
|
2005
|
|
S1 |
p. S55-S56
2 p.
|
article
|
| 10 |
2 Diseases: Management of patients presenting the first signs or a history of acute or chronic viral infection?
|
|
|
2005
|
|
S1 |
p. S15-S18
4 p.
|
article
|
| 11 |
2 Diseases: Management of patients presenting the first signs or a history of adverse reactions of anti-TNFα?
|
|
|
2005
|
|
S1 |
p. S22-S25
4 p.
|
article
|
| 12 |
2 Diseases: Management of patients presenting the first signs or a history of autoimmune disease?
|
|
|
2005
|
|
S1 |
p. S3-S5
3 p.
|
article
|
| 13 |
2 Diseases: Management of patients presenting the first signs or a history of demyelinating disease?
|
|
|
2005
|
|
S1 |
p. S6-S8
3 p.
|
article
|
| 14 |
2 Diseases: Management of patients presenting the first signs or a history of haematological disease other than lymphoma?
|
|
|
2005
|
|
S1 |
p. S9-S14
6 p.
|
article
|
| 15 |
2 Diseases: Management of patients presenting the first signs or a history of heart failure?
|
|
|
2005
|
|
S1 |
p. S19-S21
3 p.
|
article
|
| 16 |
2 Diseases: Management of patients presenting the first signs or a history of lymphoma?
|
|
|
2005
|
|
S1 |
p. S26-S30
5 p.
|
article
|
| 17 |
2 Diseases: Management of patients presenting the first signs or a history of solid malignancy?
|
|
|
2005
|
|
S1 |
p. S31-S38
8 p.
|
article
|
| 18 |
2 Diseases: Management of patients presenting the first signs or a history of thrombosis?
|
|
|
2005
|
|
S1 |
p. S39-S40
2 p.
|
article
|
| 19 |
2 Diseases: Management of patients presenting the first signs or a history of tuberculosis?
|
|
|
2005
|
|
S1 |
p. S41-S45
5 p.
|
article
|
| 20 |
2 Diseases: Management of patients presenting the first signs or a history of vasculitis?
|
|
|
2005
|
|
S1 |
p. S46-S48
3 p.
|
article
|
| 21 |
4 Example of information letter to the patient's attending physician
|
|
|
2005
|
|
S1 |
p. S59-S60
2 p.
|
article
|
| 22 |
Foreword
|
Bardin, Thomas
|
|
2015
|
|
S1 |
p. eS1-
1 p.
|
article
|
| 23 |
Identifying Patient Candidates for IL-1 Inhibition: Lessons From Real-World Cases
|
Avram, Annalina
|
|
2015
|
|
S1 |
p. eS17-eS29
nvt p.
|
article
|
| 24 |
1 Main symptoms to be monitored during anti-TNFα therapy and differential diagnosis
|
|
|
2005
|
|
S1 |
p. S1-
1 p.
|
article
|
| 25 |
Practical management of patients on Janus kinase inhibitor (JAKi) therapy: Practical fact sheets drawn up by the Rheumatism and Inflammation Club (CRI), a group endorsed by the French Society for Rheumatology (SFR)
|
RICHEZ, Christophe
|
|
|
|
S1 |
p. eS2-eS103
|
article
|
| 26 |
Practical management of patients on Janus kinase inhibitor (JAKi) therapy - the CRI fact sheets
|
RICHEZ, Christophe
|
|
|
|
S1 |
p. eS1
|
article
|
| 27 |
Rituximab (MabThera) therapy and safety management. Clinical tool guide developed by the Rheumatic Diseases & Inflammation Group (Club Rhumatismes et Inflammation, CRI) of the French Society for Rheumatology (Société Française de Rhumatologie, SFR)
|
Pham, Thao
|
|
2008
|
|
S1 |
p. S2-S99
98 p.
|
article
|
| 28 |
The Human and Economic Burden of Difficult-to-Treat Gouty Arthritis
|
Voshaar, Martijn A.H. Oude
|
|
2015
|
|
S1 |
p. eS2-eS8
nvt p.
|
article
|
| 29 |
The Way Forward: Practical Clinical Considerations for the Use of Canakinumab in Patients With Difficult-to-Treat Gouty Arthritis
|
Bardin, Thomas
|
|
2015
|
|
S1 |
p. eS30-eS32
nvt p.
|
article
|
| 30 |
TNF alpha antagonist therapy and safety monitoring
|
Pham, Thao
|
|
2011
|
|
S1 |
p. 15-185
171 p.
|
article
|
| 31 |
Tocilizumab: Therapy and safety management
|
Pham, Thao
|
|
2010
|
|
S1 |
p. S3-S100
98 p.
|
article
|
Journal description